SEARCH RESULTS

CJEU – Phoenix v. Harting

Preliminary ruling under Article 267 TFEU in the case between Phoenix Contact GmbH & Co. KG v. HARTING Deutschland GmbH & Co. KG, Harting Electric GmbH & Co. KG, 28 April 2022, Case No. C‑44/21, ECLI:EU:C:2022:309 “By its question, the referring court asks, in essence, whether Article 9(1) of Directive 2004/48 must be interpreted as […]

FOUND IN: BLOG

EPLAW – YOUNG EPLAW 2022 Annual Congress

After a three year covid-related hiatus, the Young EPLAW event finally took place in person again in Brussels yesterday. The event was preceded by a mock trial and a social event on Sunday. The program was busy and varied, with topics ranging from ‘Hot topics in FRAND litigation’ to ‘Confidentiality in court proceedings’ ,  ‘Cross […]

FOUND IN: BLOG

NL – Novartis v. Mylan

Novartis versus Mylan, PI judge District Court of The Hague 22 March 2022, ECLI:NL:RBDHA:2022:2490 (interlocutory decision) Market entry by the generic pharmaceutical company Mylan before the grant of a Novartis patent – which will be infringed once granted – is not unlawful. Not even if Novartis’ patent will be granted with certainty and the wording […]

FOUND IN: BLOG

ES – SHARK HELMETS v. TECH DESIGN TEAM

Shark Helmets S.A.S. v. Tech Design Team S.L., Commercial Court no. 5 of Barcelona, 28 October 2021, Docket No. 729/2020 In this decision issued on 28 October 2021, Barcelona first instance Patent Courts examined the question of interpreting the extent of protection of the claims in view of the patent description and drawings. The plaintiff, […]

FOUND IN: BLOG

Young EPLAW – 25th April 2022

The Young EPLAW Congress will be held on 25th April 2022 at The Hotel Brussels, 38 Boulevard de Waterloo, Bruxelles, 1000, Belgium, Grand Ballroom, 1st Floor.  Please see attached program.

FOUND IN: CONGRESS